https://doi.org/10.1002/eji.200939889
L
Luca Zammataro
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
140
Papers
4.7K
Citations
35
h-index
50
i10-index
Luca Zammataro is an academic researcher from Texas Medical Center. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Cancer Genomics and Diagnostics & Protein Degradation and Inhibitors. The author has an h-index of 35, co-authored 119 publications.
ORCID: 0000-0002-4348-6341Papers by this author
worksDifferential regulation of iron homeostasis during human macrophage polarized activation
2009 · European Journal of Immunology · 410 citations
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy
2019 · Proceedings of the National Academy of Sciences · 93 citations
https://doi.org/10.1073/pnas.1911385116
NOTCH3 expression is linked to breast cancer seeding and distant metastasis
2018 · Breast Cancer Research · 83 citations
https://doi.org/10.1186/s13058-018-1020-0
Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan
2020 · Scientific Reports · 59 citations
https://doi.org/10.1038/s41598-020-58009-3
SYD985, a novel duocarmycin-based HER2-targeting antibody-drug conjugate, shows promising antitumor activity in epithelial ovarian carcinoma with HER2/Neu expression
2017 · Gynecologic Oncology · 46 citations
https://doi.org/10.1016/j.ygyno.2017.04.023
Exome sequencing identifies CTSK mutations in patients originally diagnosed as intermediate osteopetrosis
2013 · Bone · 30 citations
https://doi.org/10.1016/j.bone.2013.11.014
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat